The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Group</td><td class="align_center">7 months old</td><td class="align_center">Perimenopausal<sup>+</sup></td><td class="align_center">After treatment<sup>+</sup></td></tr><tr><td class="align_left" colspan="4"><hr/></td></tr><tr><td class="align_left">No treatment</td><td class="align_center">330.67 ± 18.61</td><td class="align_center">344.56 ± 19.08</td><td class="align_center">347.67 ± 20.19</td></tr><tr><td class="align_left">Saline-treated</td><td class="align_center">347.13 ± 30.32</td><td class="align_center">343.75 ± 36.46</td><td class="align_center">343.75 ± 27.78</td></tr><tr><td class="align_left">Yougui-treated</td><td class="align_center">330.20 ± 21.05</td><td class="align_center">340.60 ± 21.31</td><td class="align_center">320.80 ± 27.99</td></tr><tr><td class="align_left">Zuogui-treated</td><td class="align_center">339.83 ± 34.87</td><td class="align_center">334.33 ± 27.13</td><td class="align_center">327.83 ± 23.95</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div><sup>+</sup>4 weeks after the blood samples were taken.<br/></div></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab4

Table 4

Table 4: The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency 